AAMDSIF Podcast for Patients: MDS - Inqovi Treatment with Dr. Amer Zeidan
Dr. Amer Zeidan from Yale School of Medicine explains the uses, benefits, and risks of the newly approved treatment, Inqovi.
AAMDSIF Podcasts for Patients
Share:
Listens: 0
About
"Podcasts for Patients" from the Aplastic Anemia and MDS International Foundation. For more, see our podcast page at: https://www.aamds.org/podcast/
AAMDSIF Podcast Episode 49: Dr. Eunice Wang discusses Secondary MDS
Dr. Eunice Wang explains the origin and treatment of secondary MDS. Dr. Wang is the Chief of the Leukemia Service at Roswell Park Comprehensive Center...
AAMDSIF SERIES Podcast Episode 48: Dr David Steensma discusses MDS and toxins
Dr. David Steensma discusses MDS and toxins with Leigh Clark, Patient Educator. Dr. Steensma is an associate professor at Harvard Medical School and f...
AAMDSIF Podcast Episode 47: Dr. Yacoub explains MDS-MPNs overlap
Dr. Abdulraheem Yacoub talks with Leigh Clark about MDS-MPNs overlap. He includes how molecular testing is used in determining treatment options. He a...
AAMDSIF Podcast Episode 45: PAN Foundation's grants for patients
During COVID-19, the PAN Foundation is giving grants to certain AML and CML patients. Listen to this broadcast to learn the details.
AAMDSIF Podcast for Patients Episode 46: Luspatercept with Dr. Amit Verma
Discussion of the recent approval of Luspatercept with Doctor Amit Verma, Director of the Division of Hematologic Malignancies and a Professor of Onco...
AAMDSIF Podcast for Patients Episode 44: Dr. Gustavo Rivero on Low-Risk MDS and Supportive Care
Dr. Gustavo Rivero describes strategies for management of Low-Risk MDS, or Myelodysplastic Syndromes. He details supportive care for these patients, i...
AAMDSIF Podcast Episode 43: Dr. Vu Duong
Dr Vu Duong explains risk classifications for MDS. He dives into IPSS and IPSS-R scores, focused on helping patients to understand the meanings of hig...
AAMDSIF Podcast Episode 42: Julie Lowe explains March for Marrow and other events
Julie Lowe, AAMDSIF Director for Strategic Initiatives, anticipates your questions about getting involved with the Aplastic Anemia and MDS Internation...
AAMDSIF Podcast Episode 41: MDS to AML, treatment and options with Dr. Tiffany Tanaka, UC San Diego
Dr. Tiffany Tanaka from the University of California, San Diego explains the development of High-Risk MDS into AML. She talks about new diagnostic and...